Fundraising Fox
Diality
Irvine, US · Founded 2015 · California corporation
Find your way into Diality
Sign up to see every warm intro you have to Diality
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Diality team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Diality is a medical device company developing a home hemodialysis machine and related solutions for patients with kidney disease, aimed at supporting new decentralized kidney-care models. The Series-B company serves the dialysis and nephrology market and is based in Irvine, California.
Founders & leadership
PD
Peter DonatoChief Financial Officer
AM
AARON MISHKINNamed on SEC filing
TM
TIMOTHY MCNAMARANamed on SEC filing
MR
MARTIN RIEDIKERNamed on SEC filing
AK
ATHER KHANNamed on SEC filing
MP
MARTIN PASEKNamed on SEC filing
OK
OSMAN KHAWARFounder
Funding
SEC filings, press & company announcements$71M disclosed across 5 rounds · 2018–2023
- $28MraisedAug 2023 · 4 sourcesSource ↗
▶$24.9MraisedMar 2022 · 16 investors · Other Health CareRule 506(c)
▶$24.9MraisedMar 2022 · 16 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Martin PasekDirector
- Jahnavi LokreExecutive Officer
- Daniel GuthrieExecutive Officer
- Osman KhawarExecutive Officer, Director
- Allen NissensonDirector
- Clayton PoppeExecutive Officer
- Martin RiedikerDirector
- Aaron MishkinExecutive Officer, Director
- Offering amount
- $26M
- Amount sold
- $24.9M
- Minimum investment
- $25K
- First sale
- Feb 2022
- Incorporated
- Corporation, California
- Federal exemptions
- 06c
▶$55KraisedAug 2020 · 2 investors · Other Health CareRule 506(c)
▶$55KraisedAug 2020 · 2 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- JAHNAVI LOKREExecutive Officer
- AARON MISHKINExecutive Officer, Director
- MARTIN PASEKDirector
- ATHER KHANExecutive Officer
- MARTIN RIEDIKERDirector
- OSMAN KHAWARExecutive Officer, Director
- CLAYTON POPPEExecutive Officer
- Offering amount
- $15M
- Amount sold
- $55K
- Minimum investment
- $25K
- First sale
- Aug 2020
- Incorporated
- Corporation, California, 2015
- Federal exemptions
- 06c
▶$10MraisedNov 2019 · 14 investors · Other Health CareRule 506(c)
▶$10MraisedNov 2019 · 14 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- OSMAN KHAWARExecutive Officer, Director
- MARTIN PASEKDirector
- TIMOTHY MCNAMARAExecutive Officer, Director
- CLAYTON POPPEExecutive Officer
- JAHNAVI LOKREExecutive Officer
- ATHER KHANExecutive Officer
- MARTIN RIEDIKERDirector
- AARON MISHKINExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $10M
- Minimum investment
- $25K
- First sale
- Jun 2019
- Incorporated
- Corporation, California, 2015
- Federal exemptions
- 06c
▶$8MraisedDec 2018 · 6 investors · Other Health CareRule 506(c)
▶$8MraisedDec 2018 · 6 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- AARON MISHKINExecutive Officer, Director
- TIMOTHY MCNAMARAExecutive Officer, Director
- MARTIN RIEDIKERDirector
- ATHER KHANExecutive Officer
- MARTIN PASEKDirector
- OSMAN KHAWARExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Jun 2018
- Incorporated
- Corporation, California, 2015
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
DiabetomicsModalityDx develops quantitative point-of-care diagnostic tests using molecular biomarkers and data science to detect and assess treatment response for diseases including diabetes, maternal health conditions, and autoimmune disorders. The company also supports pharmaceutical firms in drug development and therapeutic efficacy assessment.
KidneyThe National Kidney Foundation works to eliminate preventable kidney disease, accelerate innovation in patient care, and address structural inequities in kidney treatment and transplantation services. The organization serves patients with kidney disease and at-risk communities.
Outset MedicalOutset Medical develops dialysis technology aimed at driving broader adoption and lowering the cost of care for patients and healthcare providers. The company manufactures in North America and operates across the United States.
Companies working in the same space as Diality.
In the news
Frequently asked questions
- What does Diality do?
- Diality is a medical device company developing a home hemodialysis machine and related solutions for patients with kidney disease, aimed at supporting new decentralized kidney-care models. The Series-B company serves the dialysis and nephrology market and is based in Irvine, California.
- How much funding has Diality raised?
- Diality has disclosed $71M raised across 5 rounds.
- Where is Diality headquartered?
- Diality is headquartered in Irvine, US.